Results 151 to 160 of about 9,240 (233)

E094 BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis from the ixekizumab COAST-V study in radiographic axial spondyloarthritis [PDF]

Martín Rudwaleit, Victoria Navarro Compán, H.H. Russ, Tommaso Panni, Erica Filippi, Mani Haschemi Nassab, Soyi Liu-Léage, Vincent Goëb, Francesco Ciccia, Jean Dudler, Maureen Todd   +10 more
openalex   +1 more source

HIGH BASDAI SCORES DID NOT REDUCE IMMUNE RESPONSE TO PLANNED YELLOW FEVER PRIMARY VACCINATION IN SPONDYLOARTHRITIS

, 2021
Thays Zanon Casagrande, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, Arthur Dalmaso Pinto, Priscila Costa Martins Rocha, Emily Hime Miranda, Lauro Ferreira da Silva Pinto-Neto, Érica Vieira Serrano, Valquíria Garcia Dinis, Sônia Alves Gouvêa, João Gabriel Fragoso Dias, Maria Bernadete Renoldi de Oliveira Gavi, Lídia Balarini da Silva, Valéria Valim, Olindo Assis Martins‐Filho, Ismael Artur da Costa-Rocha, Vanessa Peruhype-Magalhães, Andréa Teixeira‐Carvalho, Ana Carolina Campi‐Azevedo, Elizandra Polito, Gisela Freitas Trindade, Ruben Horst Duque, Ana Paula Espíndula Gianórdoli, Sheila Maria Barbosa de Lima, LETÍCIA RESENDE BRANDÃO   +24 more
openalex   +1 more source

Different Acupuncture Therapies Combined with Sulfasalazine for the Treatment of Ankylosing Spondylitis: Bayesian Network Meta-Analysis. [PDF]

J Pain Res
Han K, Yu M, Chen J, Wang S.
europepmc   +1 more source

Factors affecting employment in Japanese patients with ankylosing spondylitis (AS). [PDF]

BMC Rheumatol
Furusawa H, Tada K, Hayashi E, Inoue H, Kobayashi S, Yamaji K, Tamura N.   +6 more
europepmc   +1 more source

Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study). [PDF]

Front Med (Lausanne)
Campos C, Fito-Manteca MC, Valero-Martínez C, García-Carazo S, Almodóvar R, Díaz-Cerezo S, Moyano S, Cobo A, Aguirregabiria I, Pérez-Rambla C, Pérez-Sádaba FJ, Navarro-Compán V.   +11 more
europepmc   +1 more source

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. [PDF]

RMD Open
Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, D'Agostino MA, Gaffney K, Kay J, de la Loge C, Massow U, Taieb V, Vaux T, Deodhar A.   +13 more
europepmc   +1 more source

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis [PDF]

Martín Rudwaleit, Victoria Navarro‐Compán, H.H. Russ, Tommaso Panni, Erica Filippi, Mani Haschemi Nassab, Soyi Liu-Léage, Vincent Goëb, Francesco Ciccia, Jean Dudler   +9 more
openalex   +1 more source

Efficacy & safety of adalimumab biosimilar in axial spondyloarthritis: A retrospective study from a tertiary care centre in South India. [PDF]

Indian J Med Res
Gopalan A, Gavali M, Yerram K.
europepmc   +1 more source

Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study. [PDF]

Reumatologia
Koç E, Okyar B, Bakırcı S, Badak SÖ, Demir AN, Uçar İ, Sargın G, Yüce S, Ersözlü ED.   +8 more
europepmc   +1 more source

Axial spondyloarthritis treatment patterns, clinical characteristics and patient-reported outcome collection in US rheumatology practices. [PDF]

Rheumatol Adv Pract
Concoff A, Taiji R, Grinnell-Merrick L, Rodrigues J, McDermott C, Haber R, Ionescu-Ittu R, Faucher A, Vekeman F, Nguyen T.   +9 more
europepmc   +1 more source